Balyasny Asset Management’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-313,796
| Closed | -$14.5M | – | 1791 |
|
|
2019
Q2 | $14.5M | Buy |
+313,796
| New | +$8.81M | 0.09% | 299 |
|
|
2019
Q1 | – | Sell |
-31,579
| Closed | -$450K | – | 1791 |
|
|
2018
Q4 | $450K | Sell |
31,579
-374,309
| -92% | -$5.68M | ﹤0.01% | 1122 |
|
|
2018
Q3 | $6.17M | Buy |
405,888
+367,640
| +961% | +$5.63M | 0.03% | 633 |
|
|
2018
Q2 | $642K | Sell |
38,248
-279,360
| -88% | -$4.44M | ﹤0.01% | 1265 |
|
|
2018
Q1 | $5.18M | Sell |
317,608
-1,505,196
| -83% | -$24.1M | 0.02% | 700 |
|
|
2017
Q4 | $23.3M | Buy |
1,822,804
+1,479,245
| +431% | +$16.8M | 0.07% | 355 |
|
|
2017
Q3 | $4.23M | Sell |
343,559
-375,565
| -52% | -$3.49M | 0.02% | 767 |
|
|
2017
Q2 | $6.02M | Buy |
719,124
+560,124
| +352% | +$4.58M | 0.02% | 703 |
|
|
2017
Q1 | $1.42M | Sell |
159,000
-1,230,775
| -89% | -$13.1M | 0.01% | 1008 |
|
|
2016
Q4 | $12.2M | Buy |
+1,389,775
| New | +$10.2M | 0.07% | 419 |
|
|
2016
Q3 | – | Sell |
-32,090
| Closed | -$114K | – | 1394 |
|
|
2016
Q2 | $114K | Sell |
32,090
-17,700
| -36% | -$57.7K | ﹤0.01% | 1094 |
|
|
2016
Q1 | $147K | Buy |
49,790
+1,430
| +3% | +$4.29K | ﹤0.01% | 1165 |
|
|
2015
Q4 | $204K | Sell |
48,360
-22,090
| -31% | -$101K | ﹤0.01% | 1090 |
|
|
2015
Q3 | $321K | Sell |
70,450
-2,740
| -4% | -$16.2K | ﹤0.01% | 901 |
|
|
2015
Q2 | $528K | Buy |
+73,190
| New | +$540K | ﹤0.01% | 851 |
|
|
2014
Q2 | – | Sell |
-2,070,626
| Closed | -$9.73M | – | 834 |
|
|
2014
Q1 | $9.73M | Buy |
2,070,626
+868,426
| +72% | +$4.37M | 0.11% | 231 |
|
|
2013
Q4 | $6.02M | Buy |
1,202,200
+89,516
| +8% | +$487K | 0.08% | 285 |
|
|
2013
Q3 | $6.92M | Buy |
1,112,684
+554,744
| +99% | +$3.3M | 0.09% | 291 |
|
|
2013
Q2 | $2.53M | Buy |
+557,940
| New | +$3M | 0.04% | 418 |
|